Stephen Uden
About Stephen Uden
Stephen Uden is a Co-Founder of Rallybio, where he has worked since 2018. He has held various leadership roles in the pharmaceutical industry, including positions at Alexion Pharmaceuticals and Pfizer.
Work at Rallybio
Stephen Uden has served as Co-Founder at Rallybio since 2018. The company is based in Farmington, CT, and focuses on developing innovative therapies for patients with rare diseases. Uden's role involves strategic leadership and oversight of research initiatives aimed at advancing the company's mission in the biopharmaceutical sector.
Previous Experience in Pharmaceuticals
Prior to his current role, Stephen Uden held several significant positions in the pharmaceutical industry. He worked as Senior Vice President of Research at Alexion Pharmaceuticals, Inc. from 2014 to 2017. Before that, he was Vice President of Research and Development at Pfizer in Japan from 2000 to 2010, where he contributed to various R&D projects. Uden also served as Executive Vice President and Head of R&D at Neurogen Corporation from 2005 to 2007 and briefly as VP R&D Japan at Wyeth KK in 2009.
Education and Expertise
Stephen Uden studied Medicine at the University of London, where he earned a Bachelor of Science degree and the medical degrees M.B. and B.S. from 1976 to 1982. His educational background provides a strong foundation for his extensive career in pharmaceutical research and development, particularly in the areas of drug discovery and clinical development.
Career Timeline
Stephen Uden's career spans several decades in the pharmaceutical industry. He began his tenure at Pfizer in 2000, where he worked for ten years. He then transitioned to Neurogen Corporation, followed by a role at Alexion Pharmaceuticals. In 2018, he co-founded Rallybio, marking a significant step in his professional journey.